Targeting Receptor Tyrosine Kinase VEGFR-2 in Hepatocellular Cancer: Rational Design, Synthesis and Biological Evaluation of 1,2-Disubstituted Benzimidazoles

In this study, a novel series of 1,2-disubstituted benzo[d]imidazoles was rationally designed as VEGFR-2 inhibitors targeting hepatocellular carcinoma. Our design strategy is two-fold; it aimed first at studying the effect of replacing the 5-methylfuryl moiety of the well-known antiangiogenic 2-fury...

Full description

Saved in:
Bibliographic Details
Published in:Molecules
Main Authors: Abdel-Mohsen, Heba T., Abdullaziz, Mona A., El Kerdawy, Ahmed M., Ragab, Fatma A. F., Flanagan, Keith J., Mahmoud, Abeer E. E., Ali, Mamdouh M., El Diwani, Hoda I., Senge, Mathias O.
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7071059/
https://ncbi.nlm.nih.gov/pubmed/32053964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules25040770
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items